These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 18160687)
21. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping. Heemskerk HA; de Winter CL; de Kimpe SJ; van Kuik-Romeijn P; Heuvelmans N; Platenburg GJ; van Ommen GJ; van Deutekom JC; Aartsma-Rus A J Gene Med; 2009 Mar; 11(3):257-66. PubMed ID: 19140108 [TBL] [Abstract][Full Text] [Related]
22. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing. Takeshima Y; Yagi M; Matsuo M Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides. Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928 [TBL] [Abstract][Full Text] [Related]
28. Exon skipping therapy for Duchenne muscular dystrophy. Kole R; Krieg AM Adv Drug Deliv Rev; 2015 Jun; 87():104-7. PubMed ID: 25980936 [TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells. Aartsma-Rus A; Kaman WE; Bremmer-Bout M; Janson AA; den Dunnen JT; van Ommen GJ; van Deutekom JC Gene Ther; 2004 Sep; 11(18):1391-8. PubMed ID: 15229633 [TBL] [Abstract][Full Text] [Related]
30. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Yin H; Lu Q; Wood M Mol Ther; 2008 Jan; 16(1):38-45. PubMed ID: 17968354 [TBL] [Abstract][Full Text] [Related]
31. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Kinali M; Arechavala-Gomeza V; Feng L; Cirak S; Hunt D; Adkin C; Guglieri M; Ashton E; Abbs S; Nihoyannopoulos P; Garralda ME; Rutherford M; McCulley C; Popplewell L; Graham IR; Dickson G; Wood MJ; Wells DJ; Wilton SD; Kole R; Straub V; Bushby K; Sewry C; Morgan JE; Muntoni F Lancet Neurol; 2009 Oct; 8(10):918-28. PubMed ID: 19713152 [TBL] [Abstract][Full Text] [Related]
32. Injection site reactions after long-term subcutaneous delivery of drisapersen: a retrospective study. Hilhorst N; Spanoudi-Kitrimi I; Goemans N; Morren MA Eur J Pediatr; 2019 Feb; 178(2):253-258. PubMed ID: 30448867 [TBL] [Abstract][Full Text] [Related]
33. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies. Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801 [TBL] [Abstract][Full Text] [Related]
35. Overview on DMD exon skipping. Aartsma-Rus A Methods Mol Biol; 2012; 867():97-116. PubMed ID: 22454057 [TBL] [Abstract][Full Text] [Related]
36. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272 [TBL] [Abstract][Full Text] [Related]
37. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene. Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018 [TBL] [Abstract][Full Text] [Related]
38. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Helderman-van den Enden AT; Straathof CS; Aartsma-Rus A; den Dunnen JT; Verbist BM; Bakker E; Verschuuren JJ; Ginjaar HB Neuromuscul Disord; 2010 Apr; 20(4):251-4. PubMed ID: 20153965 [TBL] [Abstract][Full Text] [Related]